Signaturefd, LLC Biotechnology

Signaturefd, LLC

$5.21 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MREO Mereo Biopharma Group PLC	$372M	$2,000 0.0% of portfolio	679	Q2 2024 Reduced 17.2%
NUVL Nuvalent, Inc.	$3.49B	$2,000 0.0% of portfolio	29	Q4 2024 Reduced 3.33%
NUVB Nuvation Bio Inc.	$495M	$2,000 0.0% of portfolio	1,126	Q4 2024 Reduced 32.29%
TERN Terns Pharmaceuticals, Inc.	$160M	$2,000 0.0% of portfolio	376	Q4 2024 Added 16.41%
TGTX Tg Therapeutics, Inc.	$4.49B	$2,000 0.0% of portfolio	76	Q4 2024 Added 137.5%
QURE Uni Qure N.V.	$621M	$2,000 0.0% of portfolio	152	Q4 2024 Reduced 26.92%
ETNB 89bio, Inc.	$508M	$1,000 0.0% of portfolio	197	Q4 2024 Reduced 7.08%
CRBU Caribou Biosciences, Inc.	$76.7M	$1,000 0.0% of portfolio	750	Q2 2024 Reduced 7.64%
CPRX Catalyst Pharmaceuticals, Inc.	$2.33B	$1,000 0.0% of portfolio	94	Q4 2024 Reduced 10.48%
CRVS Corvus Pharmaceuticals, Inc.	$230M	$1,000 0.0% of portfolio	224	Q4 2024 New
EDIT Editas Medicine, Inc.	$81.8M	$1,000 0.0% of portfolio	1,440	Q4 2024 Reduced 84.56%
JANX Janux Therapeutics, Inc.	$1.53B	$1,000 0.0% of portfolio	29	Q4 2024 New
KROS Keros Therapeutics, Inc.	$263M	$1,000 0.0% of portfolio	76	Q4 2023 New
ORIC Oric Pharmaceuticals, Inc.	$380M	$1,000 0.0% of portfolio	236	Q4 2024 Reduced 14.18%
PLRX Pliant Therapeutics, Inc.	$124M	$1,000 0.0% of portfolio	124	Q3 2024 New
TNGX Tango Therapeutics, Inc.	$224M	$1,000 0.0% of portfolio	346	Q4 2024 New
VERU Veru Inc.	$44.1M	$1,000 0.0% of portfolio	3,000	Q1 2023 Reduced 0.96%
VIR Vir Biotechnology, Inc.	$1.21B	$1,000 0.0% of portfolio	179	Q4 2024 Reduced 69.4%
ACAD Acadia Pharmaceuticals Inc	$3.09B	$0 0.0% of portfolio	41	Q4 2024 Reduced 89.85%
ANNX Annexon, Inc.	$151M	$0 0.0% of portfolio	151	Q2 2024 New
ACLX Arcellx, Inc.	$2.77B	$0 0.0% of portfolio	8	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$422M	$0 0.0% of portfolio	20	Q4 2024 Reduced 72.6%
RCUS Arcus Biosciences, Inc.	$866M	$0 0.0% of portfolio	40	Q3 2024 New
ARDX Ardelyx, Inc.	$850M	$0 0.0% of portfolio	93	Q4 2024 Reduced 41.14%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	2,956	Q4 2024 Added 5.12%
COGT Cogent Biosciences, Inc.	$544M	$0 0.0% of portfolio	120	Q1 2024 Added 57.89%
IGMS Igm Biosciences, Inc.	$40M	$0 0.0% of portfolio	161	Q3 2024 Reduced 15.71%
IMNM Immunome Inc.	$123M	$0 0.0% of portfolio	13	Q4 2024 Reduced 84.52%
ITOS I Teos Therapeutics, Inc.	$259M	$0 0.0% of portfolio	8	Q4 2024 Reduced 99.84%
KALV Kal Vista Pharmaceuticals, Inc.	$227M	$0 0.0% of portfolio	81	Q4 2024 Reduced 74.92%
LRMR Larimar Therapeutics, Inc.	$135M	$0 0.0% of portfolio	8	Q4 2024 Reduced 97.53%
LXRX Lexicon Pharmaceuticals, Inc.	$128M	$0 0.0% of portfolio	388	Q4 2024 Reduced 66.95%
MRSN Mersana Therapeutics, Inc.	$66.1M	$0 0.0% of portfolio	286	Q4 2024 New
NKTR Nektar Therapeutics	$137M	$0 0.0% of portfolio	200	Q4 2023 Reduced 93.75%
OLMA Olema Pharmaceuticals, Inc.	$204M	$0 0.0% of portfolio	162	Q2 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$94.8M	$0 0.0% of portfolio	150	Q3 2023 Added 15.38%
RLAY Relay Therapeutics, Inc.	$452M	$0 0.0% of portfolio	160	Q4 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$0 0.0% of portfolio	235	Q4 2024 Added 158.24%
SANA Sana Biotechnology, Inc.	$540M	$0 0.0% of portfolio	597	Q4 2024 Reduced 15.8%
TSHA Taysha Gene Therapies, Inc.	$82.2M	$0 0.0% of portfolio	282	Q4 2024 Added 61.14%
TBPH Theravance Biopharma, Inc.	$625M	$0 0.0% of portfolio	85	Q3 2024 Reduced 73.19%
TYRA Tyra Biosciences, Inc.	$510M	$0 0.0% of portfolio	24	Q4 2024 New
URGN Uro Gen Pharma Ltd.	$241M	$0 0.0% of portfolio	22	Q4 2024 Reduced 94.21%
VCEL Vericel Corp	$2.64B	$0 0.0% of portfolio	11	Q4 2024 New
VYGR Voyager Therapeutics, Inc.	$159M	$0 0.0% of portfolio	115	Q4 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	181	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.